产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 250mg | 98% | 现货 | |||
| 1g | 98% | 现货 | |||
| 5g | 98% | 现货 | |||
| 25g | 98% | 现货 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 250mg | 98% | 现货 | |||
| 1g | 98% | 现货 | |||
| 5g | 98% | 现货 | |||
| 25g | 98% | 现货 |
CAS No. |
123447-62-1 |
|---|---|
中文名称 |
6-氟-1-甲基-7-(4-((5-甲基-2-氧代-1,3-二氧杂环戊烯-4-基)甲基)哌嗪-1-基)-4-氧代-1,4-二氢-[1,3]硫氮杂环丁烷并[3,2-a]喹啉-3-羧酸 |
英文名称 |
6-Fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)piperazin-1-yl)-4-oxo-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid |
别名 |
Prulifloxacin | 123447-62-1 | Pruvel | NM441 | Quisnon | NM-441 | Prulifloxacin [INN] | Sword | NM 441 | 6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)piperazin-1-yl)-4-oxo-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid | Prulifloxacin (hydrochl |
标准英文名 |
6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)piperazin-1-yl)-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid |
MDL No. |
MFCD00864847 |
分子式 |
C21H20FN3O6S |
分子量 |
461.47 |
精确分子量 |
461.11 |
SMILES |
O=C(C1=C(SC2C)N2C3=C(C=C(F)C(N4CCN(CC5=C(C)OC(O5)=O)CC4)=C3)C1=O)O |
标准SMILES |
CC1OC(=O)OC=1CN1CCN(CC1)C1=CC2=C(C=C1F)C(=O)C(=C1SC(C)N21)C(O)=O |
性状 |
Form: Crystal - Powder / Colour: Slightly pale yellow - Yellow |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
PWNMXPDKBYZCOO-UHFFFAOYSA-N |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
Inert atmosphere,Room Temperature,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory tract irritation (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|